Second Stage:Open-label Study of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B

Clinical trial NCT02862106 · COMPLETED

Trial details

NCT number: NCT02862106
Sponsor: Chongqing Jiachen Biotechnology Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2010-09-01
Primary completion: 2013-03-01
Enrollment: 209

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.